Department of Anesthesiology University of Wisconsin, School of Medicine and Public Health, Madison, WI.
Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Pain Physician. 2020 Jul;23(4):405-412.
This study describes the use of transversus abdominis plane (TAP) blocks to treat and manage chronic abdominal pain (CAP) in patients who have exhausted other treatment options. Typically, this is a procedure prescribed for treating acute abdominal pain following abdominal surgery. Here we evaluate the use of TAP blocks for longer relief from CAP.
To assess the efficacy of TAP blocks for pain control in patients with CAP.
This was a retrospective chart review and analysis of TAP blocks performed over 5 years. This project qualified for institutional review board exemption.
This study was completed at an academic institution.
We reviewed the charts of 92 patients who received TAP blocks for CAP after previous treatment was ineffective. Some patients underwent multiple TAP blocks, with a total of 163 individual procedures identified. For most blocks, a solution of 0.25% bupivacaine and triamcinolone was injected into the TAP. Efficacy of the injection was measured using pain scores, percent improvement, and duration of relief from pain.
TAP blocks were associated with a statistically significant (P <= 0.05) improvement in abdominal pain scores in 81.9% of procedures. Improvement was 50.3% ± 39.0% with an average duration of 108 days after procedures with ongoing pain relief at time of follow-up were removed. There was a significant reduction in emergency department visits for abdominal pain before and after the procedure (P <= 0.05).
This was a retrospective chart review with lack of a control group.
TAP blocks can be extrapolated for treating abdominal pain beyond acute settings. TAP injections can be considered as a treatment option for patients with somatosensory CAP refractory to other forms of pain management.
Abdominal pain, transversus abdominis plane block, chronic pain, chronic abdominal pain, pain management, somatosensory pain, transversus abdominis plane, steroid injection.
本研究描述了使用腹横肌平面（TAP）阻滞来治疗和管理已用尽其他治疗选择的慢性腹痛（CAP）患者。通常，这是一种用于治疗腹部手术后急性腹痛的程序。在这里，我们评估 TAP 阻滞在 CAP 更长时间缓解方面的应用。
评估 TAP 阻滞治疗 CAP 患者疼痛的疗效。
这是一项回顾性图表审查和分析，对 5 年内进行的 TAP 阻滞进行了评估。该项目符合机构审查委员会豁免条件。
本研究在学术机构完成。
我们回顾了 92 名因先前治疗无效而接受 TAP 阻滞治疗 CAP 的患者的图表。一些患者接受了多次 TAP 阻滞，共确定了 163 个单独的程序。对于大多数阻滞，将 0.25%布比卡因和曲安奈德的溶液注入 TAP。使用疼痛评分、改善百分比和疼痛缓解持续时间来衡量注射的疗效。
TAP 阻滞与 81.9%的程序中腹痛评分的统计学显著（P <= 0.05）改善相关。在有持续疼痛缓解的程序中，改善为 50.3%±39.0%，平均持续时间为 108 天，在随访时去除了正在进行的疼痛缓解。在该程序前后，因腹痛就诊的急诊次数显著减少（P <= 0.05）。
这是一项回顾性图表审查，缺乏对照组。
TAP 阻滞可扩展用于治疗急性以外的腹痛。对于对其他形式的疼痛管理有抵抗力的躯体感觉 CAP 患者，TAP 注射可被视为一种治疗选择。
腹痛、腹横肌平面阻滞、慢性疼痛、慢性腹痛、疼痛管理、躯体感觉疼痛、腹横肌平面、类固醇注射。
